Nathan Edward Millard, MD
Cancer and Blood Disorders Center, Brain Tumor Program
On staff since May 2018
-
Other Publications
-
Becher OJ, Millard NE, Modak S, Kushner BH, Haque S, Spasojevic I, Trippett TM, Gilheeney SW, Khakoo Y, Lyden DC, De Braganca KC, Kolesar JM, Huse JT, Kramer K, Cheung NV, Dunkel IJA phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
28582410 PloS one, 2017 : 12(6)e0178593 PMCID:PMC5459446 -
Millard NE, De Braganca KCMedulloblastoma.
26336203 Journal of child neurology, 2016 Oct. : 31(12)1341-53 PMCID:PMC4995146 -
Millard NE, Dunkel IJAdvances in the management of central nervous system germ cell tumors.
24838613 Current oncology reports, 2014 July : 16(7)393
-
Overview
- Board Certification(s)
-
Pediatrics
Pediatric Hematology-Oncology
- Medical/Professional School
-
George Washington University, Washington
- Residency
-
Pediatrics, Boston Children's Hospital, Boston
- Fellowship
-
Pediatric Hematology Oncology, Memorial Sloan Kettering Cancer Center, New York
Pediatric Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York